Active Biotech AB (ACTI) - Cash Flow Conversion Efficiency

Latest as of September 2025: -1.600x

Based on the latest financial reports, Active Biotech AB (ACTI) has a cash flow conversion efficiency ratio of -1.600x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.20 Million ≈ $-774.83K USD) by net assets (Skr4.50 Million ≈ $484.27K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Active Biotech AB - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Active Biotech AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ACTI total liabilities for a breakdown of total debt and financial obligations.

Active Biotech AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Active Biotech AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Siren Gold Ltd
AU:SNG
-0.050x
EV Nickel Inc
V:EVNI
-0.177x
EXA E&C Inc
KQ:054940
0.179x
Riverside Resources Inc
V:RRI
-0.062x
Madhav Copper Limited
NSE:MCL
0.566x
White Energy Company Ltd
AU:WEC
0.030x
Minox International Group Berhad
KLSE:0288
0.027x
Dalaroo Metals Ltd
AU:DAL
-0.433x

Annual Cash Flow Conversion Efficiency for Active Biotech AB (2002–2024)

The table below shows the annual cash flow conversion efficiency of Active Biotech AB from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see ACTI market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr32.07 Million
≈ $3.45 Million
Skr-40.40 Million
≈ $-4.35 Million
-1.260x +15.54%
2023-12-31 Skr30.67 Million
≈ $3.30 Million
Skr-45.74 Million
≈ $-4.92 Million
-1.492x +6.15%
2022-12-31 Skr34.51 Million
≈ $3.71 Million
Skr-54.85 Million
≈ $-5.90 Million
-1.589x -60.68%
2021-12-31 Skr46.67 Million
≈ $5.02 Million
Skr-46.17 Million
≈ $-4.97 Million
-0.989x +32.11%
2020-12-31 Skr22.11 Million
≈ $2.38 Million
Skr-32.22 Million
≈ $-3.47 Million
-1.457x -118.79%
2019-12-31 Skr53.78 Million
≈ $5.79 Million
Skr-35.81 Million
≈ $-3.85 Million
-0.666x -44.02%
2018-12-31 Skr87.92 Million
≈ $9.46 Million
Skr-40.65 Million
≈ $-4.37 Million
-0.462x +22.68%
2017-12-31 Skr77.68 Million
≈ $8.36 Million
Skr-46.45 Million
≈ $-5.00 Million
-0.598x -49.20%
2016-12-31 Skr182.56 Million
≈ $19.65 Million
Skr-73.16 Million
≈ $-7.87 Million
-0.401x +66.78%
2015-12-31 Skr180.60 Million
≈ $19.44 Million
Skr-217.89 Million
≈ $-23.45 Million
-1.206x -83.08%
2014-12-31 Skr405.31 Million
≈ $43.62 Million
Skr-267.09 Million
≈ $-28.74 Million
-0.659x -161.28%
2013-12-31 Skr405.41 Million
≈ $43.63 Million
Skr-102.25 Million
≈ $-11.00 Million
-0.252x +64.34%
2012-12-31 Skr339.92 Million
≈ $36.58 Million
Skr-240.40 Million
≈ $-25.87 Million
-0.707x -655.82%
2011-12-31 Skr501.99 Million
≈ $54.02 Million
Skr-46.97 Million
≈ $-5.05 Million
-0.094x +91.34%
2010-12-31 Skr181.76 Million
≈ $19.56 Million
Skr-196.32 Million
≈ $-21.13 Million
-1.080x +9.35%
2009-12-31 Skr188.64 Million
≈ $20.30 Million
Skr-224.77 Million
≈ $-24.19 Million
-1.192x -22.25%
2008-12-31 Skr163.61 Million
≈ $17.61 Million
Skr-159.46 Million
≈ $-17.16 Million
-0.975x +1.04%
2007-12-31 Skr189.57 Million
≈ $20.40 Million
Skr-186.70 Million
≈ $-20.09 Million
-0.985x +40.63%
2006-12-31 Skr60.36 Million
≈ $6.50 Million
Skr-100.13 Million
≈ $-10.78 Million
-1.659x -52.37%
2005-12-31 Skr176.81 Million
≈ $19.03 Million
Skr-192.51 Million
≈ $-20.72 Million
-1.089x -18.08%
2004-12-31 Skr162.30 Million
≈ $17.47 Million
Skr-149.65 Million
≈ $-16.10 Million
-0.922x +7.56%
2003-12-31 Skr289.58 Million
≈ $31.16 Million
Skr-288.83 Million
≈ $-31.08 Million
-0.997x -30.02%
2002-12-31 Skr380.27 Million
≈ $40.92 Million
Skr-291.71 Million
≈ $-31.39 Million
-0.767x --

About Active Biotech AB

ST:ACTI Sweden Biotechnology
Market Cap
$17.19 Million
Skr159.75 Million SEK
Market Cap Rank
#25489 Global
#528 in Sweden
Share Price
Skr0.06
Change (1 day)
-2.26%
52-Week Range
Skr0.04 - Skr0.34
All Time High
Skr28.53
About

Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat relapsed refractory multiple myeloma; Laquinimod, a mechanism which is in phase 1 for the treatment of severe inflammatory eye diseases, such as… Read more